retatrutide triple agonist glp-1 gip glucagon phase 2 nejm 2023 What GLP‑3 Really Is: Triple‑Receptor Drug Dual and Triple Gut Peptide

While no direct pharmacokinetic interaction has been established between GLP-1 receptor agonists and thyroid hormone replacement, the delayed gastric emptying effect of these medications could theoretically affect absorption of oral medications, including those with a narrow therapeutic index like levothyroxine

N., and Vissoci Reiche E

This is useful because extragastric impaired motility occurs in more than 40% of those with suspected gastroparesis, and gastrointestinal symptoms do not correlate well with the gastrointestinal segment affected

Patients may find themselves ruminating about health concerns, weight loss progress, or other life stressors